Tag:
ALN-VSP02
Latest Headlines
Latest Headlines
ASCO confab gives Alnylam, RNAi a shot to shine
Alnylam Pharmaceuticals ( $ALNY ) appears to looking at the annual ASCO confab--the industry's biggest cancer drug meeting--as a key stage to boost the appeal of its gene-silencing or RNAi technology.
